7
Apr
2021
The long read: Womble Bond Dickinson’s Ben Bourke takes a deep dive into how life science companies have handled their IP portfolios over the covid-19 pandemic – in particular Moderna Therapeutics’ pledge not to enforce patents relating to its vaccine – and examines how such adjustments can prepare the ground for future inventions Read more
25
Mar
2021
A surge in life sciences applications offset a disappointing performance in other areas, the latest EPO statistics suggest Read more
16
Mar
2021
“You could go through a practice of 30 years, never experiencing what we have just been through in a year,” says Julie Anne Gillespie in exclusive interview alongside colleague James Ryan Read more
9
Mar
2021
Providing new insights into recent filings, but patent landscape uncertainties may pose dangers in the wake of the pandemic Read more
